Clinical Trial Update: Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating PM01183 in combination with Olaparib for advanced solid tumors, including ovarian, endometrial, and breast cancers; current …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Endometrial Cancer
• Ovarian Cancer

Drugs mentioned

• Olaparib (Olaparib)
• PM01183 (PM01183)

Snippet

Sponsor: Poveda, Andrés, M.D. | Conditions: Advanced Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN